Microba Life Sciences Limited (ASX:MAP)
Australia · Delayed Price · Currency is AUD 0.0350
0.00 (0.00%)
Oct 28, 2026, 4:10 PM AEDT
Microba Life Sciences Market Cap
Microba Life Sciences has a market cap or net worth of 24.51 million as of October 27, 2026. It is the 37,896th most valuable company in the world and the 1,003rd biggest in Australia. Its market cap has decreased by 49.05% in one year.
Market Cap
24.51M
Enterprise Value
20.67M
Revenue
14.76M
Global Rank
Country Rank
#1,003 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since April 5, 2022, Microba Life Sciences's market cap has decreased from 96.03M to 24.51M, a decrease of -74.47%. That is a compound annual growth rate of -25.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 24.51M | -47.04% |
| Dec 31, 2025 | 46.28M | -47.00% |
| Dec 31, 2024 | 87.33M | 8.33% |
| Dec 29, 2023 | 80.61M | -29.31% |
| Dec 30, 2022 | 114.03M | 18.75% |
| Apr 5, 2022 | 96.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 542.19M |
| Healius | 315.88M |
| Monash IVF Group | 278.59M |
| Identifai Genetics | 92.15M |
| Cryosite | 58.57M |
| BCAL Diagnostics | 27.65M |
| Rhythm Biosciences | 24.06M |
| Genetic Signatures | 19.31M |